Categories AlphaGraphs, Earnings, Finance
Paychex (PAYX) Q2 earnings top expectations; revenues rise 7%
Paychex Inc. (NASDAQ: PAYX) on Thursday said its earnings increased year-over-year in the second quarter of 2023, helped by strong revenue growth. Earnings also surpassed analysts’ consensus forecast.
Revenues of the Rochester-based human capital management solutions provider grew by 7% and reached $1.19 billion in the November quarter and matched expectations. All three operating segments registered growth.
The positive top-line performance translated into a 9% increase in adjusted net earnings to $0.99 per share in the latest quarter from $0.91 per share in the same period of 2022. Net income, including special items, was $360.3 million or $0.99 per share, up from last year’s profit of $332.1 million or $0.91 per share.
Check this space to read management/analysts’ comments on quarterly reports
Paychex’s CEO John Gibson said, “We continue to leverage our innovative HR technology and advisory solutions to help employers navigate this challenging environment. We’ve helped more than 50,000 of our clients secure available government funding through the Employee Retention Tax Credit program.”
Prior Performance
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
Microsoft (MSFT) reports higher revenue and profit for Q3 2024
Microsoft Corp. (NASDAQ: MSFT) on Thursday said its third-quarter 2024 earnings increased year-over-year, reflecting strong performance by the tech giant’s main operating segments. Third-quarter revenues came in at $61.86 billion,
GOOG, GOOGL Earnings: All you need to know about Alphabet’s Q1 2024 earnings results
Alphabet Inc. (NASDAQ: GOOG, GOOGL) reported its first quarter 2024 earnings results today. Revenues increased 15% year-over-year to $80.5 billion. Revenue growth was 16% in constant currency. Net income was
MRK Earnings: Merck Q1 2024 profit jumps on 9% revenue growth
Pharmaceutical company Merck & Co. Inc. (NYSE: MRK) reported a sharp increase in adjusted earnings for the first quarter of 2024, aided by an increase in revenues. First-quarter worldwide sales